Back to search

Article

Correlation of LOXL2 expression in non-small cell lung cancer with immunotherapy and clinical prognosis

2023-04-11

Abstract excerpt

<h4>Background: </h4> Lung cancer is the worst and deadliest disease globally, with about 80% of cases being non-small cell lung cancer (NSCLC). NSCLC mainly consists of lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD). Although chemotherapy is currently the mainstay of treatment for NSCLC, chemotherapy resistance is still an urgent problem for patients. Studies in recent years have proposed immu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
129e12e7-92a7-53b6-8be0-442e31c364d5
DOI
10.21203/rs.3.rs-2756606/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Correlation of LOXL2 expression in non-small cell lung cancer with immunotherapy and clinical prognosisDOI 10.21203/rs.3.rs-2756606/v1
Select a neighboring publication to make it the new centre.